Basma Ghazi Eid
Impact in
- Drug Discovery top 5%
- Pharmacology top 5%
- Medicinal Plant Pharmacodynamics Research
- Drug-Induced Hepatotoxicity and Protection
- Microbial Natural Products and Biosynthesis
Papers in
- Pharmacology 16
- Medicinal Plant Pharmacodynamics Research 10
- Drug-Induced Hepatotoxicity and Protection 4
- Cannabis and Cannabinoid Research 4
-
- Chemotherapy-induced organ toxicity mitigation 11
- Co-authors
- Nagla A. El‐Shitany (10 shared papers)Ashraf B. Abdel‐Naim (22 shared papers)Rasheed Ahemad Shaik (20 shared papers)Thikryat Neamatallah (15 shared papers)Gamal Abdallah Mohamed (7 shared papers)Hamdy A.A. Aly (1 shared paper)Sabrin R. M. Ibrahim (7 shared papers)Alaa Sirwi (6 shared papers)
- Journals
- Naunyn-Schmiedeberg s Archives of Pharmacology (4 papers)Nutrients (4 papers)Biomedicine & Pharmacotherapy (4 papers)Saudi Pharmaceutical Journal (3 papers)Drug Delivery (3 papers)
- Partner nations
- Saudi ArabiaEgyptUnited States
In The Last Decade
Basma Ghazi Eid
66 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 100
- Drug Discovery 11
- Pharmacology 140
- Pharmaceutical Science 97
- Biomaterials 138
- Pharmacology 156
Countries citing papers authored by Basma Ghazi Eid
This map shows the geographic impact of Basma Ghazi Eid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Basma Ghazi Eid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Basma Ghazi Eid more than expected).
Fields of papers citing papers by Basma Ghazi Eid
This network shows the impact of papers produced by Basma Ghazi Eid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Basma Ghazi Eid. The network helps show where Basma Ghazi Eid may publish in the future.
Co-authors
The 25 scholars most cited alongside Basma Ghazi Eid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 184 | |
| 2 | 2019 | 150 | |
| 3 | 2022 | 64 | |
| 4 | 2020 | 60 | |
| 5 | 2021 | 51 | |
| 6 | 2017 | 46 | |
| 7 | 2017 | 45 | |
| 8 | 2018 | 43 | |
| 9 | 2021 | 41 | |
| 10 | 2020 | 39 | |
| 11 | 2021 | 37 | |
| 12 | 2021 | 35 | |
| 13 | 2018 | 33 | |
| 14 | 2020 | 33 | |
| 15 | 2020 | 32 | |
| 16 | 2020 | 30 | |
| 17 | 2021 | 27 | |
| 18 | 2022 | 25 | |
| 19 | 2022 | 24 | |
| 20 | 2020 | 23 |
About Basma Ghazi Eid
Basma Ghazi Eid is a scholar working on Pharmacology, Pathology and Forensic Medicine, Pharmacology, Urology and Biomaterials, having authored 71 papers that have together received 1.5k indexed citations. Recurring topics across this work include Chemotherapy-induced organ toxicity mitigation (11 papers), Medicinal Plant Pharmacodynamics Research (10 papers), Nanoparticle-Based Drug Delivery (6 papers), Urinary Bladder and Prostate Research (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Cannabis and Cannabinoid Research (4 papers), Wound Healing and Treatments (4 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). The work is most often cited by research in Drug Discovery (11 citations), Pharmacology (140 citations), Pharmaceutical Science (97 citations), Biomaterials (138 citations) and Pharmacology (156 citations). Basma Ghazi Eid has collaborated with scholars based in Saudi Arabia, Egypt and United States. Frequent co-authors include Nagla A. El‐Shitany, Ashraf B. Abdel‐Naim, Rasheed Ahemad Shaik, Thikryat Neamatallah, Gamal Abdallah Mohamed, Hamdy A.A. Aly, Sabrin R. M. Ibrahim, Alaa Sirwi, Hany M. El‐Bassossy and Shaimaa G. A. Mohamed. Their work appears in journals such as Naunyn-Schmiedeberg s Archives of Pharmacology, Nutrients, Biomedicine & Pharmacotherapy, Saudi Pharmaceutical Journal and Drug Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.